As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/8/24  Anika Therapeutics, Inc.          10-Q        3/31/24   63:4.8M                                   Globenewswire Inc./FA    
  5/8/24  Anika Therapeutics, Inc.          8-K:5,9      5/2/24   15:454K                                   Globenewswire Inc./FA    
  5/8/24  Anika Therapeutics, Inc.          8-K:2,9      5/8/24   12:326K                                   Globenewswire Inc./FA    
 4/26/24  Anika Therapeutics, Inc.          10-K/A     12/31/23   15:1.6M                                   Globenewswire Inc./FA    
  4/5/24  BlackRock Inc.                    SC 13G/A               1:13K  Anika Therapeutics, Inc.          Blackrock Advisors LLC   
 3/19/24  Levitz Michael L                  4          Officer²    1:7K   Anika Therapeutics, Inc.          Globenewswire Inc./FA    
 3/19/24  Colleran David                    4          Officer²    1:7K   Anika Therapeutics, Inc.          Globenewswire Inc./FA    
 3/19/24  Nunes Anne                        4          Officer²    1:7K   Anika Therapeutics, Inc.          Globenewswire Inc./FA    
 3/19/24  Blanchard Cheryl R                4          Dir.,Off.²  1:7K   Anika Therapeutics, Inc.          Globenewswire Inc./FA    
 3/15/24  Anika Therapeutics, Inc.          10-K       12/31/23   90:9.1M                                   Globenewswire Inc./FA    
 3/13/24  Anika Therapeutics, Inc.          8-K:2,9     3/13/24   12:383K                                   Globenewswire Inc./FA    
 3/12/24  Blanchard Cheryl R                4          Dir.,Off.²  1:16K  Anika Therapeutics, Inc.          Globenewswire Inc./FA    
 3/12/24  Colleran David                    4          Officer²    1:15K  Anika Therapeutics, Inc.          Globenewswire Inc./FA    
 3/12/24  Nunes Anne                        4          Officer²    1:12K  Anika Therapeutics, Inc.          Globenewswire Inc./FA    
 3/12/24  Levitz Michael L                  4          Officer²    1:15K  Anika Therapeutics, Inc.          Globenewswire Inc./FA    
  3/6/24‡ Caligan Partners LP               SC 13D/A     3/6/24    3:116K Anika Therapeutics, Inc.          Schulte Roth & Z… LLP/FA 
          Caligan Partners LP³
          David Johnson³
          William Jellison³
 2/26/24  Anika Therapeutics, Inc.          8-K:5,9     2/24/24   10:176K                                   Globenewswire Inc./FA    
 2/13/24  Vanguard Group Inc.               SC 13G/A               1:13K  Anika Therapeutics, Inc.          Toppan Merrill/FA        
  2/9/24  Trigran Investments, Inc.         SC 13G/A               2:113K Anika Therapeutics, Inc.          Toppan Merrill/FA        
          Bradley F. Simon³
          Douglas Granat³
          Lawrence A. Oberman³
          Steven G. Simon³
          Steven R. Monieson³
  2/9/24  Dimensional Fund Advisors LP      SC 13G/A               1:17K  Anika Therapeutics, Inc.                                   

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.